Methyl 3-(1-((tert-butoxycarbonyl)amino)ethyl)benzoate, 95.0%, 1g

Adamantan-2-ylmethanamine, 97%, 500mg

2-Chloroquinoline-8-carboxylic acid, 97%, 250mg

(2S,3S)-2-((2S,3S)-2-(((Benzyloxy)carbonyl)amino)-3-methylpentanamido)-3-methylpentanoic acid, 95.0%, 100mg

GC capillary column ROTI®Cap-5, 50 m, 0.32 mm, 0.25 µm, 1 Piece(s)

2-[(2-Hydroxyethyl)disulfanyl]ethyl 2-Bromo-2-methylpropionate>95.0%(GC)1g

3-Bromo-1H-pyrazolo[4,3-c]pyridine, 95.0%, 1g

1-Boc-Pyrrolidine-3-carboxaldehyde, 95.0%, 25g

2-(5-Methylpyridin-2-yl)acetic acid hydrochloride, 95.0%, 25g

3-(2,2-difluorocyclopropyl)-1H-pyrazol-5-amine, 97%, 100mg

3-(2,4-Dihydroxyphenyl)propanoic acid, 95.0%, 5g

(2S,4R)-tert-Butyl 2-carbamoyl-4-hydroxypyrrolidine-1-carboxylate, 95.0%, 1g

2-{[(3-methyl-2-thienyl)methyl]amino}benzoic acid, 95.0%, 1g